US Stock MarketDetailed Quotes

CRISPR Therapeutics (CRSP)

Watchlist
  • 55.790
  • -0.700-1.24%
Close Sep 4 16:00 ET
  • 55.990
  • +0.200+0.36%
Post 20:02 ET
5.39BMarket Cap-11.85P/E (TTM)

About CRISPR Therapeutics Company

CRISPR Therapeutics AG is a gene editing company, which engages in the development of transformative gene-based medicines for serious diseases using its proprietary CRISPR/Cas9 platform. Its CRISPR/Cas9 platform is a gene editing technology that allows for precise, directed changes to genomic DNA. The firm offers a portfolio of therapeutic programs across a broad range of disease areas including hemoglobinopathies, oncology, regenerative medicine, and rare diseases. The company was founded by Rodger Novak, Emmanuelle Charpentier, Shaun Patrick Foy, Matthew Porteus, Daniel Anderson, Chad Cowan, and Craig Mellow on October 31, 2013 and is headquartered in Zug, Switzerland.

Company Profile

SymbolCRSP
Company NameCRISPR Therapeutics
Listing DateOct 19, 2016
Issue Price14.00
ISINCH0334081137
Founded2013
CEODr. Samarth Kulkarni, PhD
MarketNASDAQ
Employees393
Fiscal Year Ends12-31
AddressBaarerstrasse 14
CityZug
ProvinceZug
CountrySwitzerland
Zip Code6300
Phone41-41-561-32-77
Websitehttp://www.crisprtx.com

Company Executives

  • Name
  • Position
  • Salary
  • Dr. Samarth Kulkarni, PhD
  • Chairman of the Board and Chief Executive Officer
  • 7.68M
  • Naimish Patel, M.D.
  • Chief Medical Officer
  • 4.31M
  • Dr. Raju Prasad
  • Chief Financial Officer and Principal Accounting Officer
  • 3.59M
  • Sandesh Mahatme, L.L.M.
  • Independent Director
  • 353.13K
  • John T. Greene
  • Independent Director
  • 363.92K
  • Dr. Simeon J. George, M.B.A.,M.D.
  • Independent Director
  • 342.17K
  • Dr. Maria Fardis, PhD
  • Independent Director
  • 349.72K
  • Dr. Katherine A. High, M.D.
  • Independent Director
  • 358.12K
  • Dr. H. Edward Fleming, Jr,M.D.
  • Independent Director
  • 343.35K
  • Dr. Douglas A. Treco, PhD
  • Lead Independent Director
  • 370.74K
  • Dr. Christian Rommel, PhD
  • Independent Director
  • 335.74K
  • Dr. Briggs W. Morrison, M.D.
  • Independent Director
  • 341.07K
  • Dr. Ali Behbahani, M.B.A.,M.D.
  • Independent Director
  • 348.24K
  • James R. Kasinger
  • General Counsel and Secretary
  • 2.86M
Market Insights
No. Symbol 20D % Chg
Sample Name
Sample Code
 +27.84%
Sample Name
Sample Code
 +23.21%
Sample Name
Sample Code
 +20.33%
4
United Sts Brent Oil Fd Lp Unit
BNO
+19.56%
5
United States Gasoline Fund Lp
UGA
+19.32%
View More
China Concept Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +8.44%
Sample Name
Sample Code
 +8.25%
Sample Name
Sample Code
 +7.96%
4
United Microelectronics
UMC
+4.95%
5
TAL Education
TAL
+3.85%
View More
Middle East conflict spreads to the stock market! How should investors respond?
On September 1, U.S. Eastern Time, the U.S. military launched a new round of strikes against Iran in response to recent attempts by the Isla Show More
Long-term answers | Your account on the left shrinks, while your right hand is chased by the times — Be the person that no bombardment can ever wipe out.
Hormuz, Term Structure and USO: Navigating the Energy Storm

- No more -